Clínica Las Condes S.A. (LAS-CONDES.SN)
CLP 10841.0
(-1.46%)
CLP 10841.0
(-1.46%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 13.58 Billion | 49.21 Billion | 37.6 Billion | 15.82 Billion | 20.06 Billion |
| Net Income | -3.4 Billion | 4.04 Billion | 18.41 Billion | -5.27 Billion | 5.21 Billion |
| Depreciation & Amortization | 8.31 Billion | 13.41 Billion | 12.43 Billion | 12 Billion | 13.89 Billion |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | - | - | - | - | - |
| Other non-cash items | 8.68 Billion | 31.75 Billion | 6.74 Billion | 9.1 Billion | 953.88 Million |
| Investing Cash Flow | -5.59 Billion | -12.81 Billion | -2.21 Billion | -3.7 Billion | -12.9 Billion |
| Investments in PPE | -5.59 Billion | -12 Billion | -7.7 Billion | -4.2 Billion | -4.31 Billion |
| Acquisitions | - | - | - | - | - |
| Investment purchases | - | - | - | - | -8.49 Billion |
| Sales/Maturities of investments | - | - | 5.48 Billion | 498.51 Million | - |
| Other Investing Activities | -623.67 Million | -804 Million | 5.48 Billion | 498.51 Million | -86.76 Million |
| Financing Cash Flow | -22.69 Billion | -44.56 Billion | -17.05 Billion | -16.5 Billion | -17.77 Billion |
| Debt repayment | -16.94 Billion | -36.16 Billion | -14.96 Billion | -8.09 Billion | -16.42 Billion |
| Dividends payments | -1.21 Billion | -5.52 Billion | - | -1.56 Billion | -1.35 Billion |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - |
| Other Financing Activities | 31.85 Billion | 7.29 Billion | -1.21 Billion | 13.16 Billion | -1.00 |
| Accounts receivables | - | - | - | - | - |
| Accounts payables | - | - | - | - | - |
| Inventory | - | - | - | - | - |
| Other working capital | - | - | - | - | - |
| Cash at beginning of period | 19.88 Billion | 28.05 Billion | 9.71 Billion | 14.1 Billion | 24.71 Billion |
| Cash at end of period | 5.18 Billion | 19.88 Billion | 28.05 Billion | 9.71 Billion | 14.1 Billion |
| Capital Expenditure | -5.59 Billion | -12 Billion | -7.7 Billion | -4.2 Billion | -4.31 Billion |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | -14.7 Billion | -8.16 Billion | 18.33 Billion | -4.38 Billion | -10.61 Billion |
| Free Cash Flow | 7.99 Billion | 37.2 Billion | 29.9 Billion | 11.62 Billion | 15.74 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -44.54 Million | 513.55 Million | -3.4 Billion | 70.4 Million | -3.51 Billion | 786.67 Million |
| Depreciation & Amortization | 2.39 Billion | 2.47 Billion | 8.31 Billion | 179.44 Million | 3.68 Billion | 592.34 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | - | - | - |
| Other non-cash items | -4.85 Billion | 4.79 Billion | 8.68 Billion | -1.87 Billion | 2.17 Billion | 2.55 Billion |
| Investing Cash Flow | 734.67 Million | -438.17 Million | -5.59 Billion | -1.32 Billion | -1.5 Billion | -1.05 Billion |
| Investments in PPE | - | -438.17 Million | -5.59 Billion | -1.32 Billion | -1.5 Billion | -1.05 Billion |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 734.67 Million | -39.37 Million | -623.67 Million | -1000.00 | - | -611.52 Million |
| Financing Cash Flow | -554.34 Million | -7.92 Billion | -22.69 Billion | -1.39 Billion | -7.01 Billion | -6.03 Billion |
| Debt repayment | -612.9 Million | -6.75 Billion | -16.94 Billion | -235 Million | -5.64 Billion | -5.51 Billion |
| Dividends payments | - | - | -1.21 Billion | - | - | -567.93 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 25.38 Billion | 3.93 Billion | 31.85 Billion | -1.39 Billion | -7.01 Billion | -6.03 Billion |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 4.6 Billion | 5.18 Billion | 19.88 Billion | 9.52 Billion | 15.7 Billion | 18.86 Billion |
| Cash at end of period | 2.28 Billion | 4.6 Billion | 5.18 Billion | 5.18 Billion | 9.52 Billion | 15.7 Billion |
| Capital Expenditure | - | -438.17 Million | -5.59 Billion | -1.32 Billion | -1.5 Billion | -1.05 Billion |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -2.32 Billion | -575.95 Million | -14.7 Billion | -4.34 Billion | -6.18 Billion | -3.15 Billion |
| Free Cash Flow | -2.5 Billion | 7.34 Billion | 7.99 Billion | -2.95 Billion | 835.67 Million | 2.87 Billion |
DTW
2101
300862
ACGBF
000825
1767